NextCell Pharma Valuation
| NXTCL Stock | SEK 1.75 0.02 1.13% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. NextCell Pharma AB secures a last-minute Real Value of kr1.79 per share. The latest price of the firm is kr1.75. Our model forecasts the value of NextCell Pharma AB from analyzing the firm fundamentals such as Shares Outstanding of 34.38 M, operating margin of (4.75) %, and Return On Equity of -0.3 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that NextCell Pharma's price fluctuation is very risky at this time. Calculation of the real value of NextCell Pharma AB is based on 3 months time horizon. Increasing NextCell Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NextCell stock is determined by what a typical buyer is willing to pay for full or partial control of NextCell Pharma AB. Since NextCell Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NextCell Stock. However, NextCell Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.75 | Real 1.79 | Hype 1.75 | Naive 1.67 |
The intrinsic value of NextCell Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NextCell Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NextCell Pharma AB helps investors to forecast how NextCell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NextCell Pharma more accurately as focusing exclusively on NextCell Pharma's fundamentals will not take into account other important factors: NextCell Pharma Total Value Analysis
NextCell Pharma AB is now projected to have takeover price of 134.94 M with market capitalization of 255.91 M, debt of 0, and cash on hands of 150.75 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the NextCell Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
134.94 M | 255.91 M | 0 | 150.75 M |
NextCell Pharma Investor Information
About 43.0% of the company outstanding shares are owned by corporate insiders. The book value of NextCell Pharma was now reported as 3.1. The company recorded a loss per share of 0.81. NextCell Pharma AB had not issued any dividends in recent years. Based on the key measurements obtained from NextCell Pharma's financial statements, NextCell Pharma AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.NextCell Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. NextCell Pharma has an asset utilization ratio of 4.48 percent. This implies that the Company is making kr0.0448 for each dollar of assets. An increasing asset utilization means that NextCell Pharma AB is more efficient with each dollar of assets it utilizes for everyday operations.NextCell Pharma Ownership Allocation
NextCell Pharma AB maintains a total of 34.38 Million outstanding shares. NextCell Pharma AB holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.NextCell Pharma Profitability Analysis
The company reported the revenue of 5.59 M. Net Loss for the year was (35.02 M) with loss before overhead, payroll, taxes, and interest of (2.49 M).About NextCell Pharma Valuation
The stock valuation mechanism determines NextCell Pharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of NextCell Pharma AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of NextCell Pharma. We calculate exposure to NextCell Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NextCell Pharma's related companies.NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden. NextCell Pharma AB was founded in 2014 and is based in Huddinge, Sweden. NextCell Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 10 people.
8 Steps to conduct NextCell Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates NextCell Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct NextCell Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain NextCell Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine NextCell Pharma's revenue streams: Identify NextCell Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research NextCell Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish NextCell Pharma's growth potential: Evaluate NextCell Pharma's management, business model, and growth potential.
- Determine NextCell Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate NextCell Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for NextCell Stock Analysis
When running NextCell Pharma's price analysis, check to measure NextCell Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCell Pharma is operating at the current time. Most of NextCell Pharma's value examination focuses on studying past and present price action to predict the probability of NextCell Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCell Pharma's price. Additionally, you may evaluate how the addition of NextCell Pharma to your portfolios can decrease your overall portfolio volatility.